NovaBridge Biosciences (NBP) stock
NBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 7, 2026Score 0/30
$0.90+0.08 (+9.83%)
Close on Nov 18, 2026Market cap $104.20MP/E –Yield –
NovaBridge Biosciences cash
Cash and short-term investments held at the end of each period.
NovaBridge Biosciences's cash was CN¥2.28B at Dec 31, 2023. For fiscal 2023 it was CN¥2.28B, down 33.8% from the year before. The highest annual figure on record is CN¥4.79B in fiscal 2020.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | CN¥2.28B | -33.8% |
| FY2022 | Dec 31, 2022 | CN¥3.45B | -19.3% |
| FY2021 | Dec 31, 2021 | CN¥4.28B | -10.7% |
| FY2020 | Dec 31, 2020 | CN¥4.79B | +291.0% |
| FY2019 | Dec 31, 2019 | CN¥1.23B | -27.1% |
| FY2018 | Dec 31, 2018 | CN¥1.68B | +307.3% |
| FY2017 | Dec 31, 2017 | CN¥412.71M | +544.0% |
| FY2016 | Dec 31, 2016 | CN¥64.08M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2023 | Dec 31, 2023 | CN¥2.28B | -47.5% |
| Q4 FY2022 | Dec 31, 2022 | CN¥3.45B | -28.0% |
| Q2 FY2022 | Jun 30, 2022 | CN¥3.92B | +31.2% |
| Q4 FY2021 | Dec 31, 2021 | CN¥4.28B | +249.0% |
| Q2 FY2021 | Jun 30, 2021 | CN¥4.35B | +239.6% |
| Q4 FY2020 | Dec 31, 2020 | CN¥4.79B | +185.0% |
| Q3 FY2020 | Sep 30, 2020 | CN¥2.99B | +624.1% |
| Q4 FY2019 | Dec 31, 2019 | CN¥1.23B | +1812.1% |
| Q3 FY2019 | Sep 30, 2019 | CN¥1.28B | – |
| Q4 FY2018 | Dec 31, 2018 | CN¥1.68B | – |
| Q4 FY2017 | Dec 31, 2017 | CN¥412.71M | – |
| Q4 FY2016 | Dec 31, 2016 | CN¥64.08M | – |
See a number that looks wrong?